Cannabinoids do not reduce objective measurements in muscle spasticity, but people with multiple sclerosis perceive some benefit*1
GROTENHERMEN, FVolume:
8
Language:
english
Journal:
Evidence-based Healthcare
DOI:
10.1016/S1462-9410(04)00049-X
Date:
June, 2004
File:
PDF, 139 KB
english, 2004